IR BioSciences Holdings, Inc. Announces a 2-for-1 Forward Stock Split SCOTTSDALE, Ariz., April 6 /PRNewswire-FirstCall/ -- IR Biosciences...
ImmuneRegen BioSciences Holdings Inc. Establishes Research Entity in Singapore Biotech Company to Test for Efficacy in Treating SARS, Avian Flu...
FDA Requests That ImmuneRegen BioSciences Conduct an Additional Study SCOTTSDALE, Ariz., March 25 /PRNewswire/ -- During the March 12, 2004...
ImmuneRegen BioSciences Get Critical Guidance from FDA and Division of Counter Terrorism Officials Efficacy of Company's Homspera Analyzed for...
ImmuneRegen BioSciences' Homspera(TM) Deemed Dermally Non-Toxic Pre-Clinical Studies Bode Well for Future Hair Loss Applications SCOTTSDALE...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.